
Devyser Diagnostics Investor Relations Material
Latest events

Q1 2025
Devyser Diagnostics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Devyser Diagnostics
Access all reports
Devyser Diagnostics AB is a Swedish company that develops, manufactures, and sells advanced diagnostic kits for DNA testing. Their products are primarily used in the fields of hereditary diseases, oncology, and post-transplantation monitoring. These diagnostic solutions enable laboratories to conduct complex genetic tests, including those for cancer treatments, prenatal screening, and transplant patient follow-ups. The company also provides software tools for data analysis and interpretation to support their test kits. The company is headquartered in Stockholm, Sweden, and its shares are traded on the Nasdaq Stockholm.
Key slides for Devyser Diagnostics


CMD 2024
Devyser Diagnostics


Q1 2025
Devyser Diagnostics
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
DVYSR
Country
🇸🇪 Sweden